1. Elevated NLR predicts poor prognosis after resection of pancreatic ductal adenocarcinoma and it is superior to PLR as an adverse prognostic factor. (2019) Authors: Giakoustidis, A.; Neofytou, K.; Neves, M. Costa; Louri, E.; Giakoustidis, D.; Cunningham, D.; Mudan, S. Journal: HPB Issue: Volume 21(2019)Supplement 3 Page Start: S877 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Elevated NLR predicts poor prognosis after resection of pancreatic ductal adenocarcinoma and it is superior to PLR as an adverse prognostic factor. (2019) Authors: Giakoustidis, A.; Neofytou, K.; Costa Neves, M.; Louri, E.; Giakoustidis, D.; Cunningham, D.; Mudan, S. Journal: HPB Issue: Volume 21(2019)Supplement 3 Page Start: S692 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Inhibitory effect of targeted therapies of different signalling pathways in DEN-induced hepatocarcinogenesis in C57BL/6 mice. (2019) Authors: Giakoustidis, A.; Andreani, P.; Poutahidis, T.; Angelopoulou, K.; Goulopoulos, T.; Louri, E.; Papalois, A.; Mudan, S.; Giakoustidis, D.; Azoulay, D. Journal: HPB Issue: Volume 21(2019)Supplement 3 Page Start: S673 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Inhibitory effect of targeted therapies of different signalling pathways in DEN-induced hepatocarcinogenesis in C57BL/6 mice. (2019) Authors: Giakoustidis, A.; Andreani, P.; Poutahidis, T.; Angelopoulou, K.; Goulopoulos, T.; Louri, E.; Papalois, A.; Mudan, S.; Giakoustidis, D.; Azoulay, D. Journal: HPB Issue: Volume 21(2019)Supplement 3 Page Start: S813 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Nucleos(t)ide analog(s) prophylaxis after hepatitis B immunoglobulin withdrawal against hepatitis B and D recurrence after liver transplantation. Issue 5 (7th September 2016) Authors: Cholongitas, E.; Goulis, I.; Antoniadis, N.; Fouzas, I.; Imvrios, G.; Giakoustidis, D.; Giouleme, O.; Papanikolaou, V.; Akriviadis, E.; Vasiliadis, T. Journal: Transplant infectious disease Issue: Volume 18:Issue 5(2017) Page Start: 667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Successful inhibition of tumour growth in DEN-induced hepatocarcinogenesis in C57BL/6 mice with HDAC1/2 inhibitor Romidepsin. (2020) Authors: Giakoustidis, A.; Andreani, P.; Poutahidis, T.; Angelopoulou, K.; Goulopoulos, T.; Louri, E.; Papalois, A.; Gargavanis, A.; Papadopoulos, V.; Giakoustidis, D.; Azoulay, D. Journal: HPB Issue: Volume 22(2020)Supplement 2 Page Start: S380 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. TOPK Inhibitor HI-TOP-32 administration in DEN-induced hepatocarcinogenesis in C57BL/6 mice results in tumour regression. (April 2016) Authors: Giakoustidis, A.; Andreani, P.; Poutachidis, T.; Angelopoulou, K.; Mosialos, G.; Goulopoulos, T.; Papalois, A.; Papanikolaou, V.; Mudan, S.; Giakoustidis, D.; Azoulay, D. Journal: HPB Issue: Volume 18(2016)Supplement 1 Page Start: e155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗